OMNIAB, INC. Income Tax Expense
OMNIAB, INC. (OABI) reported Income Tax Expense of -$353.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-06
- OMNIAB, INC. income tax expense (benefit) for the quarter ending 2026-06-30 was -$353.00K, a 396.64% decline year-over-year.
- OMNIAB, INC. income tax expense (benefit) for the quarter ending 2026-03-31 was $442.00K.
- OMNIAB, INC. income tax expense (benefit) for the quarter ending 2025-12-31 was -$367.00K.
- OMNIAB, INC. income tax expense (benefit) for the quarter ending 2025-09-30 was -$1.16M.
- OMNIAB, INC. income tax expense (benefit) for fiscal 2025 was -$1.51M.
- OMNIAB, INC. income tax expense (benefit) for fiscal 2024 was -$9.38M.
- OMNIAB, INC. income tax expense (benefit) for fiscal 2023 was -$13.74M.
- OMNIAB, INC. income tax expense (benefit) for fiscal 2022 was -$3.73M.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$353.00K 10-Q · filed 2026-08-06 | $89.00K 10-Q · filed 2026-08-06 | -$278.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.44M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $442.00K 10-Q · filed 2026-05-07 | $75.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.09M derived: sum of 3 quarters · filed 2026-05-07 | -$967.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$367.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$1.53M derived: sum of 2 quarters · filed 2026-03-04 | -$1.41M derived: sum of 3 quarters · filed 2026-08-06 | -$1.51M 10-K · filed 2026-03-04 |
| 2025-09-30 | -$1.16M 10-Q · filed 2025-11-04 | -$1.04M derived: sum of 2 quarters · filed 2026-08-06 | -$1.15M 10-Q · filed 2025-11-04 | -$3.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $119.00K 10-Q · filed 2026-08-06 | $13.00K 10-Q · filed 2026-08-06 | -$2.14M derived: sum of 3 quarters · filed 2026-08-06 | -$4.85M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$106.00K 10-Q · filed 2026-05-07 | -$2.26M derived: sum of 2 quarters · filed 2026-05-07 | -$4.97M derived: sum of 3 quarters · filed 2026-05-07 | -$6.87M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$4.86M derived: sum of 2 quarters · filed 2026-03-04 | -$6.76M derived: sum of 3 quarters · filed 2026-03-04 | -$9.38M 10-K · filed 2026-03-04 |
| 2024-09-30 | -$2.71M 10-Q · filed 2025-11-04 | -$4.61M derived: sum of 2 quarters · filed 2025-11-04 | -$7.22M 10-Q · filed 2025-11-04 | -$13.20M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$1.90M 10-Q · filed 2025-08-06 | -$4.51M 10-Q · filed 2025-08-06 | -$10.49M derived: sum of 3 quarters · filed 2025-08-06 | -$13.79M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$2.62M 10-Q · filed 2025-05-08 | -$8.59M derived: sum of 2 quarters · filed 2025-05-08 | -$11.90M derived: sum of 3 quarters · filed 2025-05-08 | -$15.33M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$5.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$9.28M derived: sum of 2 quarters · filed 2025-03-18 | -$12.71M derived: sum of 3 quarters · filed 2025-03-18 | -$13.74M 10-K · filed 2025-03-18 |
| 2023-09-30 | -$3.30M 10-Q · filed 2024-11-12 | -$6.74M derived: sum of 2 quarters · filed 2024-11-12 | -$7.77M 10-Q · filed 2024-11-12 | -$4.95M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$3.44M 10-Q · filed 2024-08-08 | -$4.46M 10-Q · filed 2024-08-08 | -$1.65M derived: sum of 3 quarters · filed 2024-08-08 | -$3.96M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$1.03M 10-Q · filed 2024-05-09 | $1.79M derived: sum of 2 quarters · filed 2024-05-09 | -$525.00K derived: sum of 3 quarters · filed 2024-05-09 | -$2.81M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $504.00K derived: sum of 2 quarters · filed 2024-03-25 | -$1.79M derived: sum of 3 quarters · filed 2024-03-25 | -$3.73M 10-K · filed 2024-03-25 |
| 2022-09-30 | -$2.31M 10-Q · filed 2023-11-09 | -$4.60M derived: sum of 2 quarters · filed 2023-11-09 | -$6.54M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$2.29M 10-Q · filed 2023-08-10 | -$4.23M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$1.94M 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$7.31M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |